During the past decade, VieCurie Venlo, Cardiology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "VieCurie Venlo, Cardiology" are "Atherosclerotic Cardiovascular Disease" (2 trials), "Familial Hypercholesterolemia" (2 trials), "Diabetes" (1 trials), "Symptomatic Atherosclerosis" (1 trials) and "Type2 Diabetes" (1 trials). Many other conditions were trialed in "VieCurie Venlo, Cardiology" in a lesser frequency.

Most popular intervention types in "VieCurie Venlo, Cardiology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "ALN-PCSSC" (1 trials), "Evolocumab" (1 trials), "Inclisiran" (1 trials) and "Normal Saline" (1 trials). Other intervention names were less common.

The vast majority of trials in "VieCurie Venlo, Cardiology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "VieCurie Venlo, Cardiology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in VieCurie Venlo, Cardiology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in VieCurie Venlo, Cardiology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".